8-methoxy-3-(1-phenylethyl)-2,4-dihydro-1,3-benzoxazine (CED0258536)

Record Information
Version1.0
Creation Date2026-08-29 01:37:40 UTC
Update Date2026-08-29 01:37:40 UTC
Accession NumberCHEM303383
Identification
Common Name8-methoxy-3-(1-phenylethyl)-2,4-dihydro-1,3-benzoxazine
ClassSmall Molecule
Description
8-methoxy-3-(1-phenylethyl)-2,4-dihydro-1,3-benzoxazine belongs to the benzoxazines, a class of organoheterocyclic compounds within the organic compounds. This compound has the chemical formula C17H19NO2 and an average molecular weight of 269.34 g/mol. It has been found in or released from four recorded sources, specifically electrical and electronic equipment. These sources include magnets, colour television systems, line transmission systems, and amplifiers.
Contaminant TypeNot Available
Chemical Structure
MOLSDFPDBSMILESInChI
SynonymsNot Available
Chemical FormulaC17H19NO2
Average Molecular MassNot Available
Monoisotopic Mass269.142 g/mol
CAS Registry Number59004-60-3
IUPAC NameNot Available
Traditional NameNot Available
SMILESCC(C1=CC=CC=C1)N2CC3=C(C(=CC=C3)OC)OC2
InChI IdentifierInChI=1S/C17H19NO2/c1-13(14-7-4-3-5-8-14)18-11-15-9-6-10-16(19-2)17(15)20-12-18/h3-10,13H,11-12H2,1-2H3
InChI KeyCTKOKSZTCSYSMC-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
3954.0Log mg/kg[2200:7000]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
505AmplifiersElectrical & Electronic EquipmentNot Available
509Colour Television SystemsElectrical & Electronic EquipmentNot Available
525Line Transmission SystemsElectrical & Electronic EquipmentNot Available
527MagnetsElectrical & Electronic EquipmentNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)430.74
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)531.165
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)749.532
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)510.068
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)352.735
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)615.943
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)465.149
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)936.448
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)670.282
5-hydroxytryptamine receptor 7 structureClick to view 3D structure5-hydroxytryptamine receptor 7P34969HumansPredicted (SEA)672.695
Click to view 3D structure5-hydroxytryptamine receptor 7P32305Rattus norvegicusPredicted (SEA)202.33
Substance-P receptor structureClick to view 3D structureSubstance-P receptorP25103HumansPredicted (SEA)465.772
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)1142.2
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)1654.69
Click to view 3D structureNorepinephrine transporterQ9WTR4Rattus norvegicusPredicted (SEA)189.096
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)1199.03
Muscarinic acetylcholine receptor M5 structureClick to view 3D structureMuscarinic acetylcholine receptor M5P08912HumansPredicted (SEA)534.124
Click to view 3D structure5-hydroxytryptamine receptor 2AP14842Rattus norvegicusPredicted (SEA)794.451
Click to view 3D structureAlpha-1D adrenergic receptorP25100HumansPredicted (SEA)538.25
5-hydroxytryptamine receptor 2B structureClick to view 3D structure5-hydroxytryptamine receptor 2BP41595HumansPredicted (SEA)1326.55
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)2769.49
Click to view 3D structureSubstance-P receptorP14600Rattus norvegicusPredicted (SEA)268.035
D(4) dopamine receptor structureClick to view 3D structureD(4) dopamine receptorP21917HumansPredicted (SEA)1215.93
Click to view 3D structure5-hydroxytryptamine receptor 1BP28564Rattus norvegicusPredicted (SEA)389.48
Click to view 3D structureSubstance-P receptorP30547Cavia porcellusPredicted (SEA)234.793
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available